Koken Ltd. (TYO:7963)

CTI BioPharma Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,779	2,531	2,978	2,386	2,187	1,564
Cash & Short-Term Investments	3,779	2,531	2,978	2,386	2,187	1,564
Cash Growth	4.02%	-15.01%	24.81%	9.10%	39.83%	4.83%
Receivables	4,061	4,847	4,283	4,262	3,856	3,156
Inventory	2,655	2,421	2,308	2,413	1,796	1,995
Other Current Assets	226	218	209	188	149	145
Total Current Assets	10,721	10,017	9,778	9,249	7,988	6,860
Property, Plant & Equipment	9,319	9,277	9,438	9,685	10,052	10,552
Long-Term Investments	1,079	1,056	1,087	1,076	1,026	1,017
Other Intangible Assets	56	56	48	56	55	54
Long-Term Deferred Tax Assets	373	458	464	500	477	519
Other Long-Term Assets	1	2	2	2	2	2
Total Assets	21,549	20,866	20,817	20,568	19,600	19,004
Accounts Payable	418	341	273	304	239	300
Accrued Expenses	257	658	649	700	614	684
Short-Term Debt	800	805	1,425	1,445	1,465	1,485
Current Portion of Long-Term Debt	1,664	1,674	1,394	1,140	1,023	962
Current Portion of Leases	-	8	52	112	147	138
Current Income Taxes Payable	41	387	254	472	321	464
Other Current Liabilities	767	254	275	237	299	292
Total Current Liabilities	3,947	4,127	4,322	4,410	4,108	4,325
Long-Term Debt	3,460	2,686	3,170	3,374	3,324	3,157
Long-Term Leases	-	10	8	60	169	208
Other Long-Term Liabilities	191	175	169	147	167	165
Total Liabilities	8,386	7,831	8,465	8,750	8,488	8,538
Common Stock	674	674	674	674	674	674
Additional Paid-In Capital	549	549	549	549	542	534
Retained Earnings	11,807	11,723	11,177	10,702	10,053	9,418
Treasury Stock	-306	-274	-279	-282	-161	-152
Comprehensive Income & Other	439	363	231	175	4	-8
Shareholders' Equity	13,163	13,035	12,352	11,818	11,112	10,466
Total Liabilities & Equity	21,549	20,866	20,817	20,568	19,600	19,004
Total Debt	5,924	5,183	6,049	6,131	6,128	5,950
Net Cash (Debt)	-2,145	-2,652	-3,071	-3,745	-3,941	-4,386
Net Cash Per Share	-433.87	-536.42	-621.50	-754.51	-787.27	-876.17
Filing Date Shares Outstanding	4.93	4.95	4.94	4.94	5.04	5.02
Total Common Shares Outstanding	4.93	4.95	4.94	4.94	5.01	5.01
Working Capital	6,774	5,890	5,456	4,839	3,880	2,535
Book Value Per Share	2672.29	2635.66	2499.02	2391.85	2219.78	2090.74
Tangible Book Value	13,107	12,979	12,304	11,762	11,057	10,412
Tangible Book Value Per Share	2660.92	2624.33	2489.31	2380.52	2208.80	2079.95

Updated Feb 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.